Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

AdvisorShares Pure US Cannabis ETF MSOS

The investment seeks long-term capital appreciation. The fund is an actively managed ETF that seeks to achieve its investment objective by investing, under normal circumstances, at least 80% of its net assets (plus any borrowings for investment purposes) in securities of companies that derive at least 50% of their net revenue from the marijuana and hemp business in the United States and in derivatives that have economic characteristics similar to such securities. It will concentrate at least 25% of its investments in the pharmaceuticals, biotechnology and life sciences industry group within the health care sector. The fund is non-diversified.


ARCA:MSOS - Post by User

AdvisorShares Pure US Cannabis ETF
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(12)
•••
Post by Bullknit101on Nov 05, 2021 11:15pm
80 Views
Post# 34095118

Rare Cannabinoid Pharmaceuticals

Rare Cannabinoid PharmaceuticalsOnce the US MSOS take off, rare cannabinoids are right behind them and will be the next hypergrowth area. Rare cannabinoid are those other than CBD and THC that are abundant in the plant. Cannabinoids will be the class of Big Pharma drugs: https://investors.inmedpharma.com/news-releases/news-release-details/inmed-pharmaceuticals-files-pct-patent-application-treating/
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities